ACTU Bios Equity COF, LP bought ACTUATE THERAPEUTICS, INC. shares — SEC Form 4BUYACTUATE THERAPEUTICS, INC.

Bios Equity COF, LP, Director, 10% Owner at ACTUATE THERAPEUTICS, INC. (ACTU), bought 71,428 shares at $7.00 ($500K) on 2025-06-27, disclosed to the SEC on 2025-06-30.

SEC EDGAR Filing

0001104659-25-063993

View on SEC EDGAR

Why this matters (generating…)

High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.

Strong73/100

Clearly above the average filing.

First-Time BuyerBuying the Dip10% Owner PurchaseOpportunistic BuyDeep Dip Buy

Trade Context

•Increased holdings by 57%
•Buying near 52-week low (+3% from bottom)
•2 other insiders also purchased in last 30 days
•Stock down -45% in previous month

Filing Info

Filed2025-06-30

Traded2025-06-27

Accession0001104659-25-063993

SourceSEC EDGAR (Historical)

Insider

NameBios Equity COF, LP

TitleDirector, 10% Owner

PIT GradeInsiderUnrated

View Company View Insider

Get an email when an insider at ACTU files

Free account. Follow ACTU and up to 10 more companies.

Follow ACTU for free

ACTU Bios Equity COF, LP bought ACTUATE THERAPEUTICS, INC. shares — SEC Form 4BUYACTUATE THERAPEUTICS, INC.

Trade Context

Filing Info

Insider

Trade Details

Outcomes